METHOD AND APPARATUS FOR MEASURING CANCEROUS CHANGES FROM REFLECTANCE SPECTRAL MEASUREMENTS OBTAINED DURING ENDOSCOPIC IMAGING
    24.
    发明申请
    METHOD AND APPARATUS FOR MEASURING CANCEROUS CHANGES FROM REFLECTANCE SPECTRAL MEASUREMENTS OBTAINED DURING ENDOSCOPIC IMAGING 审中-公开
    用于测量内镜成像期间获得的反射光谱测量的变化的方法和装置

    公开(公告)号:US20090270702A1

    公开(公告)日:2009-10-29

    申请号:US11722822

    申请日:2006-01-20

    Abstract: The present invention provides a new method and device for disease detection, more particularly cancer detection, from the analysis of diffuse reflectance spectra measured in vivo during endoscopic imaging. The measured diffuse reflectance spectra are analyzed using a specially developed light-transport model and numerical method to derive quantitative parameters related to tissue physiology and morphology. The method also corrects the effects of the specular reflection and the varying distance between endoscope tip and tissue surface on the clinical reflectance measurements. The model allows us to obtain the absorption coefficient (μa) and further to derive the tissue micro-vascular blood volume fraction and the tissue blood oxygen saturation parameters. It also allows us to obtain the scattering coefficients (μs and g) and further to derive the tissue micro-particles volume fraction and size distribution parameters.

    Abstract translation: 本发明提供了一种用于疾病检测,特别是癌症检测的新方法和装置,其用于在内窥镜成像期间在体内测量的漫反射光谱。 使用特别开发的光传输模型和数值方法分析测量的漫反射光谱,以得出与组织生理学和形态相关的定量参数。 该方法还可以校正镜面反射和内窥镜尖端与组织表面之间距离变化对临床反射率测量的影响。 该模型允许我们获得吸收系数(mua),并进一步导出组织微血管血液体积分数和组织血氧饱和度参数。 它还允许我们获得散射系数(mus和g),并进一步导出组织微粒体积分数和尺寸分布参数。

    Apparatus for in vivo imaging of the respiratory tract and other internal organs
    27.
    发明授权
    Apparatus for in vivo imaging of the respiratory tract and other internal organs 失效
    用于呼吸道和其他内脏器官的体内成像的装置

    公开(公告)号:US06546272B1

    公开(公告)日:2003-04-08

    申请号:US09602202

    申请日:2000-06-22

    Abstract: Apparatus for acquiring in vivo images of a site of interest within the internal organs of a body. The apparatus includes an elongate, flexible catheter. The catheter is introducible into the body and has a first end that remains external to the body and a second and positionable adjacent the site of interest. A movable scanning unit having at least one sensor for acquiring images is housed adjacent the second end of the catheter. There is a drive mechanism to control movement of the movable scanning unit from the first external end of the catheter to acquire multiple images of the site of interest. The drive mechanism has a control element extending the length of the catheter lumen adapted for linear movement within the lumen to generate linear or rotational movement of the scanning unit.

    Abstract translation: 用于获取身体内部器官内的感兴趣部位的体内图像的装置。 该装置包括细长的柔性导管。 导管可引入体内,并具有保持在身体外部的第一端,并且可以邻近感兴趣部位定位第二端。 具有用于获取图像的至少一个传感器的可移动扫描单元容纳在导管的第二端附近。 存在驱动机构,用于控制可移动扫描单元从导管的第一外端的移动,以获取感兴趣部位的多个图像。 驱动机构具有延伸导管管腔长度的控制元件,其适于在内腔内线性运动,以产生扫描单元的线性或旋转运动。

    APPARATUS AND METHODS FOR CHARACTERIZATION OF LUNG TISSUE BY RAMAN SPECTROSCOPY
    28.
    发明申请
    APPARATUS AND METHODS FOR CHARACTERIZATION OF LUNG TISSUE BY RAMAN SPECTROSCOPY 审中-公开
    拉曼光谱法鉴定肺组织的装置及方法

    公开(公告)号:US20130231573A1

    公开(公告)日:2013-09-05

    申请号:US13521218

    申请日:2011-01-21

    CPC classification number: A61B5/0075 A61B5/0071 A61B5/0084 G01N21/65

    Abstract: Near-infrared Raman spectroscopy can be applied to identify preneoplastic lesions of the bronchial tree. Real-time in vivo Raman spectra of lung tissues may be obtained with a fiber optic catheter passed down the instrument channel of a bronchoscope. Using prototype apparatus, preneoplastic lesions were detected with sensitivity and specificity of 96 and 91% respectively. The use of Raman spectroscopy apparatus and methods in conjunction with other bronchoscopy imaging modalities can substantially reduce the number of false positive results.

    Abstract translation: 近红外拉曼光谱可用于鉴定支气管树瘤的肿瘤前病变。 肺组织的实时体内拉曼光谱可以通过沿支气管镜仪器通道向下传播的光纤导管获得。 使用原型装置,分别检测到96和91%的敏感性和特异性的癌前病变。 使用拉曼光谱设备和方法与其他支气管镜检查成像模式联合可以大大减少假阳性结果的数量。

Patent Agency Ranking